- Author:
Qin-Qin XU
1
,
2
;
Hui-Yan SUN
3
;
Feng-Jun XIAO
3
;
Xue-Feng SHI
1
;
Yu-Xiang LI
3
;
Hua WANG
3
;
Li-Sheng WANG
4
;
Ri-Li GE
5
Author Information
- Publication Type:Journal Article
- From: Journal of Experimental Hematology 2017;25(4):965-969
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVETo clarify the roles of SPK pathway in the regulation of proliferation, survival and glucose consume of human erythroleukemia TF-1 cells.
METHODSThe interfering in SPK expression of TF-1 cells was performed using leutivirus vector-mediated shRNA, the interference efficacy of SPK in TF-1 cells was detected by RT-qPCR and Western blot, the viability of TF-1 cell proliferation was detected by using CCK-8 method, the apoptosis of TF-1 cells was determined by flow cytmetry with Annexin V staining.
RESULTSHypoxia up-regulated the expression of HIF-1α, HIF-2α, and SPK in TF-1 cells. SPK treatment resulted in reduced proliferation and induced apoptosis in TF-1 cells. Furthermore, knockdown of the SPK significantly reduced utilization and consumption of glucose.
CONCLUSIONThe SPK is key signalling molecule involved in regulation of hypoxia-induced proliferation and glucose metabolism in TF-1 cells, and plays an important rote in proliferation and energy metabolism of leukemia cells.